Prevotella copri in individuals at risk for rheumatoid arthritis
- PMID: 30760471
- DOI: 10.1136/annrheumdis-2018-214514
Prevotella copri in individuals at risk for rheumatoid arthritis
Abstract
Objectives: Rheumatoid arthritis (RA) has been associated with a relative expansion of faecal Prevotellaceae. To determine the microbiome composition and prevalence of Prevotella spp. in a group of individuals at increased risk for RA, but prior to the development of the disease.
Methods: In an ongoing cohort study of first-degree relatives (FDRs) of patients with RA, we identified 'FDR controls', asymptomatic and without autoantibodies, and individuals in pre-clinical RA stages, who had either developed anticitrullinated peptide antibodies or rheumatoid factor positivity and/or symptoms and signs associated with possible RA. Stool sampling and culture-independent microbiota analyses were performed followed by descriptive statistics and statistical analyses of community structures.
Results: A total of 133 participants were included, of which 50 were categorised as 'FDR controls' and 83 in 'pre-clinical RA stages'. The microbiota of individuals in 'pre-clinical RA stages' was significantly altered compared with FDR controls. We found a significant enrichment of the bacterial family Prevotellaceae, particularly Prevotella spp., in the 'pre-clinical RA' group (p=0.04).
Conclusions: Prevotella spp. enrichment in individuals in pre-clinical stages of RA, before the onset of RA, suggests a role of intestinal dysbiosis in the development of RA.
Keywords: epidemiology of ra; microbiome; pre-clinical stages of ra; rheumatoid arthritis.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study.Ann Rheum Dis. 2021 Jul;80(7):e103. doi: 10.1136/annrheumdis-2019-216565. Epub 2019 Nov 19. Ann Rheum Dis. 2021. PMID: 31744823 No abstract available.
-
Response to: 'Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by Inamo.Ann Rheum Dis. 2021 Jul;80(7):e104. doi: 10.1136/annrheumdis-2019-216637. Epub 2019 Nov 28. Ann Rheum Dis. 2021. PMID: 31780524 No abstract available.
-
Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study.Ann Rheum Dis. 2022 Jan;81(1):e3. doi: 10.1136/annrheumdis-2019-216747. Epub 2020 Jan 10. Ann Rheum Dis. 2022. PMID: 31924601 No abstract available.
Similar articles
-
Evidence of the Immune Relevance of Prevotella copri, a Gut Microbe, in Patients With Rheumatoid Arthritis.Arthritis Rheumatol. 2017 May;69(5):964-975. doi: 10.1002/art.40003. Epub 2017 Apr 7. Arthritis Rheumatol. 2017. PMID: 27863183 Free PMC article.
-
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine.Arthritis Rheumatol. 2016 Nov;68(11):2646-2661. doi: 10.1002/art.39783. Arthritis Rheumatol. 2016. PMID: 27333153
-
First-degree relatives of patients with rheumatoid arthritis exhibit high prevalence of joint symptoms.J Rheumatol. 2013 Jun;40(6):818-24. doi: 10.3899/jrheum.121016. Epub 2013 Mar 15. J Rheumatol. 2013. PMID: 23504380
-
Infectious Triggers in Periodontitis and the Gut in Rheumatoid Arthritis (RA): A Complex Story About Association and Causality.Front Immunol. 2020 Jun 3;11:1108. doi: 10.3389/fimmu.2020.01108. eCollection 2020. Front Immunol. 2020. PMID: 32582191 Free PMC article. Review.
-
Contribution of HLA DRB1, PTPN22, and CTLA4, to RA dysbiosis.Joint Bone Spine. 2022 Nov;89(6):105446. doi: 10.1016/j.jbspin.2022.105446. Epub 2022 Aug 6. Joint Bone Spine. 2022. PMID: 35940545 Review.
Cited by
-
Segatella clades adopt distinct roles within a single individual's gut.NPJ Biofilms Microbiomes. 2024 Oct 27;10(1):114. doi: 10.1038/s41522-024-00590-w. NPJ Biofilms Microbiomes. 2024. PMID: 39465298 Free PMC article.
-
Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis.Nat Rev Rheumatol. 2024 Oct;20(10):601-613. doi: 10.1038/s41584-024-01154-0. Epub 2024 Sep 9. Nat Rev Rheumatol. 2024. PMID: 39251771 Review.
-
Effects of probiotics supplementation in gastrointestinal complications and quality of life of patients with systemic sclerosis: A systematic review.Heliyon. 2024 Aug 13;10(16):e36230. doi: 10.1016/j.heliyon.2024.e36230. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39247342 Free PMC article. Review.
-
CHIKV infection drives shifts in the gastrointestinal microbiome and metabolites in rhesus monkeys.Microbiome. 2024 Aug 30;12(1):161. doi: 10.1186/s40168-024-01895-w. Microbiome. 2024. PMID: 39223641 Free PMC article.
-
Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients.NPJ Biofilms Microbiomes. 2024 Aug 28;10(1):73. doi: 10.1038/s41522-024-00549-x. NPJ Biofilms Microbiomes. 2024. PMID: 39191760 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous